Anti-inflammatory effect of resveratrol on adjuvant arthritis rats with abnormal immunological function via the reduction of cyclooxygenase-2 and prostaglandin E2

Molecular Medicine Reports

Volumn 9, Issue 6, 2014, Pages 2592-2598

  Chen, Xiaoyu ^a   Lu, Jinseng ^a   An, Mei ^a   Ma, Zhongfei ^a   Zong, Hexiang ^a   Yang, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Adjuvant arthritis; Immune; Inflammation; Rat; Resveratrol

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CELECOXIB; CYCLOOXYGENASE 2; PROSTAGLANDIN E2; RESVERATROL; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ELISA KIT; HISTOPATHOLOGY; IN VITRO STUDY; MALE; NONHUMAN; PAW EDEMA; PROTEIN EXPRESSION; RAT; RHEUMATOID ARTHRITIS; SPLEEN CELL; STAINING; SYNOVIUM; WESTERN BLOTTING; ANIMAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BLOOD; DRUG EFFECTS; IMMUNOLOGY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CYCLOOXYGENASE 2; DINOPROSTONE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; RATS; STILBENES; SYNOVIAL MEMBRANE;

EID: 84899671900     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2070     Document Type: Article

References (32)

1. Karmakar S, Kay J and Gravallese EM: Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention. Rheum Dis Clin North Am 36: 385-404, 2010.
2. Mattey DL, Glossop JR, Nixon NB and Dawes PT: Circulating levels of tumor necrosis factor receptors are highly predictive of mortality in patients with rheumatoid arthritis. Arthritis Rheum 56: 3940-3948, 2007. (Pubitemid 350262319)
3. Bax M, van Heemst J, Huizinga TW and Toes RE: Genetics of rheumatoid arthritis: what have we learned? Immunogenetics 63: 459-466, 2011.
4. Chen XY, Li J, Cheng WM, Jiang H, Xie XF and Hu R: Effect of total flavonoids Chrysanthemum indicum on the apoptosis of synoviocytes in joint of adjuvant arthritis rats. Am J Chin Med 36: 695-704, 2008.
5. Bereswill S, Muñoz M, Fischer A, Plickert R, Haag LM, Otto B, Kühl AA, Loddenkemper C, Göbel UB and Heimesaat MM: Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One 5: e15099, 2010.
6. Kavas GO, Ayral PA and Elhan AH: The effects of resveratrol on oxidant/ antioxidant systems and their cofactors in rats. Adv Clin Exp Med 22: 151-155, 2013.
7. Tyagi A, Gu M, Takahata T, Frederick B, Agarwal C, Siriwardana S, Agarwal R and Sclafani RA: Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma. Clin Cancer Res 17: 5402-5411, 2011.
8. Kundu JK, Shin YK, Kim SH and Surh YJ: Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. Carcinogenesis 27: 1465-1474, 2006. (Pubitemid 43994860)
9. Yar AS, Menevse S and Alp E: The effects of resveratrol on cyclooxygenase-1 and -2, nuclear factor kappa beta, matrix metalloproteinase-9, and sirtuin 1 mRNA expression in hearts of streptozotocin-induced diabetic rats. Genet Mol Res 10: 2962-2975, 2011.
10. Shindler KS, Ventura E, Dutt M, Elliott P, Fitzgerald DC and Rostami A: Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J Neuroophthalmol 30: 328-339, 2010.
11. Singh NP, Hegde VL, Hofseth LJ, Nagarkatti M and Nagarkatti P: Resveratrol (trans-3,5,4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor. Mol Pharmacol 72: 1508-1521, 2007. (Pubitemid 350146088)
12. Chen XY, Wang ZC, Li J, Liu XL and Sun YH: Regulation of synoviocyte activity by resveratrol in rats with adjuvant arthritis. Exp Ther Med 6: 172-176, 2013.
13. Tian J, Chen JW, Gao JS, Li L and Xie X: Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway. Rheumatol Int 33: 1829-1835, 2013.
14. Elmali N, Baysal O, Harma A, Esenkaya I and Mizrak B: Effects of resveratrol in inflammatory arthritis. Inflammation 30: 1-6, 2007. (Pubitemid 46438042)
15. El-Ghazaly MA, Nada AS, El-Hazek RM and Khayyal MT: Effect of selective COX-2 inhibitor, celecoxib on adjuvant-induced arthritis model in irradiated rats. Int J Radiat Biol 86: 1079-1087, 2010.
16. Chen XY, Li J, Cheng WM, Jiang H, Zhang L and Hu R: Effect of total flavonoids Chrysanthemum indicum on ultrastructure and secretory function of synoviocytes in adjuvant arthritis rats. Lat Am J Pharm 30: 2031-2036, 2011.
17. Yifan W, Dengming W, Zheng L, Yanping L and Junkan S: Triptolide inhibits CCR5 expressed in synovial tissue of rat adjuvant-induced arthritis. Pharmacol Rep 59: 795-799, 2007. (Pubitemid 351586575)
18. Bolon B, Morony S, Cheng Y, Hu YL and Feige U: Osteoclast numbers in Lewis rats with adjuvant-induced arthritis: identification of preferred sites and parameters for rapid quantitative analysis. Vet Pathol 41: 30-36, 2004. (Pubitemid 38146844)
19. Leech M, Xue JR, Dacumos A, Hall P, Santos L, Yang Y, Li M, Kitching AR and Morand EF: The tumour suppressor gene p53 modulates the severity of antigen-induced arthritis and the systemic immune response. Clin Exp Immunol 152: 345-353, 2008. (Pubitemid 351520912)
20. Chang Y, Wu Y, Wang D, Wei W, Qin Q, Xie G, Zhang L, Yan S, Chen J, Wang Q, Wu H, Xiao F, Sun W, Jin J and Wang W: Therapeutic effects of TACI-Ig on rats with adjuvant-induced arthritis via attenuating inflammatory responses. Rheumatology (Oxford) 50: 862-870, 2011.
21. Zheng FL, Chang Y, Jia XY, Huang M and Wei W: Effects and mechanisms of Cryptotanshinone on rats with adjuvant arthritis. Chin Med J (Engl) 124: 4293-4298, 2011.
22. Xuzhu G, Komai-Koma M, Leung BP, Howe HS, McSharry C, McInnes IB and Xu D: Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Ann Rheum Dis 71: 129-135, 2012.
23. Bevaart L, Vervoordeldonk MJ and Tak PP: Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis? Arthritis Rheum 62: 2192-2205, 2010.
24. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, Radstake TR, Heuvelmans-Jacobs M, Akira S, Nicklin MJ, Ribeiro-Dias F and van den Berg WB: Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 118: 205-216, 2008.
25. Aizman E, Blacher E, Ben-Moshe O, Kogan T, Kloog Y and Mor A: Therapeutic effect of farnesylthiosalicylic acid on adjuvant-induced arthritis through suppressed release of inflammatory cytokines. Clin Exp Immunol 175: 458-467, 2014.
26. Song SS, Huang B, Wang QT, Wu YJ, Fu JJ, Zhang YF, Chang Y, Chen JY, Wu HX, Wang D, Zhang LL and Wei W: BF02, a recombinant TNFR2 fusion protein, alleviates adjuvant arthritis by regulating T lymphocytes in rats. Acta Pharmacol Sin 34: 414-423, 2013.
27. Lichtenberger LM, Barron M and Marathi U: Association of phosphatidylcholine and NSAIDs as a novel strategy to reduce gastrointestinal toxicity. Drugs Today (Barc) 45: 877-890, 2009.
28. Half EE and Arber N: Chemoprevention of colorectal cancer: two steps forward, one step back? Future Oncol 2: 697-704, 2006. (Pubitemid 44941987)
29. Bjarnason I, Macpherson A, Rotman H, Schupp J and Hayllar J: A randomized, double-blind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen. Scand J Gastroenterol 32: 126-130, 1997. (Pubitemid 27075117)
30. Gheorghe KR, Thurlings RM, Westman M, Boumans MJ, Malmström V, Trollmo C, Korotkova M, Jakobsson PJ and Tak PP: Prostaglandin E2 synthesizing enzymes in rheumatoid arthritis B cells and the effects of B cell depleting therapy on enzyme expression. PLoS One 6: e16378, 2011.
31. Beavis PA, Gregory B, Green P, Cribbs AP, Kennedy A, Amjadi P, Palfreeman AC, Feldmann M and Brennan FM: Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cells. Proc Natl Acad Sci USA 108: 16717-16722, 2011.
32. Nakayama H, Yaguchi T, Yoshiya S and Nishizaki T: Resveratrol induces apoptosis MH7A human rheumatoid arthritis synovial cells in a sirtuin 1-dependent manner. Rheumatol Int 32: 151-157, 2007.